Nonpredictable pharmacokinetic behavior of high-dose cyclophosphamide in combination with cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Yago Nieto(The University of Texas MD Anderson Cancer Center), R B Jones, S Matthes, Scott I. Bearman(University of Washington), Pablo J. Cagnoni(University of Colorado Hospital), Xiyuan Xu(Capital Medical University), E.J. Shpall, James R. Murphy(University of Liverpool)
PubMed
April 1, 1999
Cited by 28
Related Papers
Genetic Epidemiology of COPD (COPDGene) Study Design
|COPD Journal of Chronic Obstructive Pulmonary Disease|2010|1.3k
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
|Journal of Allergy and Clinical Immunology|2007|933
The Clinical Significance of Positive Blood Cultures: A Comprehensive Analysis of 500 Episodes of Bacteremia and Fungemia in Adults. I. Laboratory and Epidemiologic Observations
|Clinical Infectious Diseases|1983|754